Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
32 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Abdelrahman Kamel Fathy Mohammed 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
34 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
35 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Dr. Marwa Tammam Ameen Hammam 2023
36 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
37 Intracardiac Extension of Malignant Tumors: A Case Series with Seven Cases Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed 2023
38 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
39 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
40 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022